文献速递炎症性肠病

饮食疗法可快速诱导活动期儿童克罗恩病应答与缓解

Dietary Therapies Induce Rapid Response and Remission in Pediatric Patients With Active Crohn's Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-04-14

该研究基于CDED多中心随机试验的73例轻中度活动期儿童克罗恩病患者,比较CDED联合部分肠内营养与全肠内营养的疗效。结果显示第3周时两组多数患者达到快速应答,第3周缓解可提高第6周缓解几率,而依从性差降低第6周缓解几率。

要点

  • 饮食疗法(CDED或EEN)可在第3周快速诱导活动期儿童CD临床应答
  • 第3周达到缓解者第6周缓解几率更高(OR 6.37)
  • 依从性差与第6周缓解几率降低相关

核心结论

  • 对活动期儿童克罗恩病,CDED与EEN饮食疗法均可在第3周诱导快速临床应答。
  • 识别第3周有无快速应答可能有助于判断依从患者能否在第6周达到临床缓解。

研究设计与样本

  • 基于CDED多中心随机试验的数据分析,纳入73例轻中度活动期儿童克罗恩病患者(平均年龄14.2±2.7岁)。
  • 患者随机接受全肠内营养(EEN,n=34)或CDED联合50%部分肠内营养(n=39),在基线及第3、6周评估。
  • 缓解定义为CD活动指数评分低于10,应答定义为评分下降12.5分或临床缓解,炎症以C反应蛋白评估。

主要发现

  • 第3周时CDED组82%、EEN组85%的患者达到饮食快速应答或缓解(DiRe)。
  • 血清C反应蛋白中位水平从基线24 mg/L降至第3周5.0 mg/L(P < .001)。
  • 第6周达到缓解的49例中,46例(94%)曾出现DiRe,81%在第3周已临床缓解。
  • 多因素分析中,第3周缓解增加第6周缓解的比值比(OR 6.37;95%CI 1.6-25;P = .008)。
  • 依从性差降低第6周缓解的比值比(OR 0.75;95%CI 0.012-0.46;P = .006)。

临床怎么用

  • 对活动期儿童CD可考虑CDED或EEN饮食疗法,并在第3周评估快速应答以辅助预测第6周缓解。
  • 应重视饮食疗法依从性,依从性差与第6周缓解几率降低相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Dietary therapies based on exclusion of usual dietary elements induce remission in children with Crohn's disease (CD), whereas re-exposure induces rebound inflammation. We investigated whether a short trial of dietary therapy, to identify patients with and without a rapid response or remission on the diet (DiRe), can be used to predict success or failure of long-term dietary therapy. METHODS: We collected data from the multicenter randomized trial of the CD exclusion diet (CDED). We analyzed data from 73 children with mild to moderate CD (mean age, 14.2 ± 2.7 y) randomly assigned to groups given either exclusive enteral nutrition (EEN, n = 34) or the CDED with 50% (partial) enteral nutrition (n = 39). Patients were examined at baseline and at weeks 3 and 6 of the diet. Remission was defined as CD activity index scores below 10 and response was defined as a decrease in score of 12.5 points or clinical remission. Inflammation was assessed by measurement of C-reactive protein. RESULTS: At week 3 of the diet, 82% of patients in the CDED group and 85% of patients in the EEN group had a DiRe. Median serum levels of C-reactive protein had decreased from 24 mg/L at baseline to 5.0 mg/L at week 3 (P < .001). Among the 49 patients in remission at week 6, 46 patients (94%) had a DiRe and 81% were in clinical remission by week 3. In multivariable analysis, remission at week 3 increased odds of remission by week 6 (odds ratio, 6.37; 95% CI, 1.6-25; P = .008) whereas poor compliance reduced odds of remission at week 6 (odds ratio, 0.75; 95% CI, 0.012-0.46; P = .006). CONCLUSIONS: For pediatric patients with active CD, dietary therapies (CDED and EEN) induce a rapid clinical response (by week 3). Identification of patients with and without a rapid response to diet might help identify those who, with compliance, will be in clinical remission by week 6 of the diet. ClinicalTrials.gov no: NCT01728870.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Sigall Boneh R, Van Limbergen J, Wine E, et al. Dietary Therapies Induce Rapid Response and Remission in Pediatric Patients With Active Crohn's Disease. Clin Gastroenterol Hepatol. 2020. PMID: 32302709. doi:10.1016/j.cgh.2020.04.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。